Bharat Biotech’s Covaxin to be ready by June 2021

  • Bharat Biotech has said that Covaxin, its ICMR-backed vaccine for Covid-19, is set for launch in June 2021. The Hyderabad-based vaccine maker, which has received approval for phase 3 trials, will enroll 26,000 volunteers for the late-stage testing in November. The trials will be conducted at around 30 sites in the country.

  • The Executive Director of Bharat Biotech has said that the vaccine will be ready for launch by June 2021 unless the government authorises its emergency use.

  • Bharat biotech has enrolled 1000 volunteers for the phase-II trials and none of the participants reported any adverse side effects of the administered vaccine. The company had applied for authorisation from the DGCI to conduct phase-III trials

  • India's Zydus Cadila is currently conducting mid-stage trials of its own vaccine hopeful, while Serum Institute is making potential vaccines from AstraZeneca, Novavax and Codagenix Inc, as well as developing its own.


Subscribe to us

Thanks for submitting!

  • Instagram
  • Twitter
  • LinkedIn
  • Facebook




the breif bulletin logo